Ro 23-3423 is a thromboxane synthase inhibitor that can be used in the study of general anesthesia; it increases plasma levels of PGF and PGE2 in a dose-dependent manner, accompanied by a decrease in mean systemic arterial pressure and systemic vascular resistance.